How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAbbreviations
Abrir esta carpeta y ver su contenido1 INTRODUCTION
Cerrar esta carpeta2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Abrir esta carpeta y ver su contenidoOrganization of the national formulary committee
Ver el documentoAgreement on purpose, content, structure and format
Ver el documentoFinancing
Ver el documentoSelection of medicines to be included in the national formulary
Ver el documentoDevelopment of the draft
Ver el documentoReviewing and finalizing content
Ver el documentoProduction, dissemination and implementation
Ver el documentoEvaluation and review
Abrir esta carpeta y ver su contenido3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Abrir esta carpeta y ver su contenido4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Abrir esta carpeta y ver su contenido5 ADDITIONAL SOURCES OF INFORMATION
Abrir esta carpeta y ver su contenido6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Abrir esta carpeta y ver su contenido7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Abrir esta carpeta y ver su contenido8 EVALUATION
Abrir esta carpeta y ver su contenido9 REVIEW AND UPDATE
Ver el documentoREFERENCES
 

Agreement on purpose, content, structure and format

The WMF could serve as a model for the structure, content and depth of information provided in a NF. However, depending on the intended audience and purpose of the NF, substantial differences will still exist between countries with regard to inclusion of local drug policies, synopses of national guidelines and locally collected information on medicines. Therefore, the NFC and the editors should clearly define these attributes of the formulary and identify the procedures necessary to achieve them.

Important structural and formatting decisions regarding classification, indexing, number of sections, technicality of language, etc. will need to be made early in the drafting process. The development of a NF can be greatly facilitated by the extensive adoption of WMF structures and content. Clearly the intended purpose of a NF will strongly influence whether the NF will be a slim, compact drug handbook or a more substantial and comprehensive drug reference book. However, a balance will have to be struck between including all possible information and producing a manageable volume for everyday use. It is useful to look at other published formularies at this planning stage to obtain helpful ideas.

Developing a small “pilot” draft section of the formulary based on the WMF and discussing content and format issues again before the entire draft is developed can be a useful way to save editorial time and make production of the draft consistent.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013